{"id":"W2801498551","doi":"10.1016/j.dadm.2018.03.004","title":"Challenges associated with biomarker‐based classification systems for Alzheimer's disease","year":2018,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"European Social Fund; National Institute on Aging; Instituto de Salud Carlos III; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Institutes of Health; Genentech; IXICO; H. Lundbeck A/S; Servier; Eisai; Generalitat de Catalunya; Northern California Institute for Research and Education; Pfizer; Biogen; BioClinica; University of Southern California; Novartis Pharmaceuticals Corporation; U.S. Public Health Service; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; F. Hoffmann-La Roche; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas; Alzheimer's Drug Discovery Foundation; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Alzheimer's Association; Foundation for the National Institutes of Health","keywords":"Biomarker; Disease; Medicine; Alzheimer's disease; Internal medicine; Oncology; Biology; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009638707,0.0006152269,0.0005727261,0.0004071403,0.0006398041,0.0003404806,0.000339877,0.0001192182,0.0001460234],"category_scores_gemma":[0.0001909329,0.0005464303,0.0003323034,0.0004840766,0.0002902064,0.0004710392,0.0001189705,0.0002134745,0.00004196332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001580282,"about_ca_system_score_gemma":0.0008163335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003960306,"about_ca_topic_score_gemma":0.000007706331,"domain_scores_codex":[0.9950207,0.0003439308,0.0006873379,0.001241598,0.001602848,0.001103539],"domain_scores_gemma":[0.9955696,0.0005467919,0.0003930821,0.0008829192,0.001247486,0.001360067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00109062,0.003134467,0.9516117,0.0001348208,0.01141384,0.00008432196,0.00003436776,0.00001086824,0.0002262536,0.0002993756,0.001335371,0.03062397],"study_design_scores_gemma":[0.004119149,0.001031794,0.9511775,0.00118036,0.02920273,8.571376e-7,0.000324206,0.006905941,0.001753519,0.00004461987,0.003659916,0.0005994498],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7505844,0.215978,0.004675436,0.008217397,0.002865945,0.01333924,0.0005227879,0.0009945021,0.002822234],"genre_scores_gemma":[0.9861115,0.001612779,0.0006383865,0.0001532859,0.0008725968,0.00975658,0.0006880517,0.0001472631,0.00001957112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2355271,"threshold_uncertainty_score":0.9996987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1306193865718007,"score_gpt":0.3912767702229022,"score_spread":0.2606573836511016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}